Role of size of drug delivery carriers for pulmonary and intravenous administration with emphasis on cancer therapeutics and lung-targeted drug delivery-Reference-Cited by-同舟云学术

Role of size of drug delivery carriers for pulmonary and intravenous administration with emphasis on cancer therapeutics and lung-targeted drug delivery

Published:2014 Issue:62 Volume:4 Page:32673-32689
ISSN:2046-2069
Container-title:RSC Adv.
language:en
Short-container-title:RSC Adv.

Author:

Dhand Chetna¹²³,Prabhakaran Molamma P.⁴⁵⁶⁷⁸,Beuerman Roger W.¹²³⁹¹⁰,Lakshminarayanan R.¹²³⁹¹⁰,Dwivedi Neeraj¹¹⁷¹²,Ramakrishna Seeram⁴⁵⁶⁷⁸

Affiliation:

1. Anti-Infectives Research Group

2. Singapore Eye Research Institute

3. Singapore 168751, Singapore

4. Center for Nanofibers and Nanotechnology

5. Nanoscience and Nanotechnology Initiative

6. Faculty of Engineering

7. National University of Singapore

8. Singapore 117576

9. Duke-NUS SRP Neuroscience and Behavioral Disorders

10. Singapore 169857, Singapore

11. Department of Electrical and Computer Engineering

12. Singapore117576, Singapore

Abstract

The design of a drug delivery system and the fabrication of efficient, successful, and targeted drug carriers are two separate issues that require slightly different design parameters.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2014/RA/C4RA02861A

Reference119 articles.

1. Drug delivery systems: An updated review

2. Size of IgG-Opsonized Particles Determines Macrophage Response during Internalization

3. Blood clearance and organ deposition of intravenously administered colloidal particles. The effects of particle size, nature and shape

4. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system

5. Nanotechnology in Medicine: From Inception to Market Domination

Cited by 91 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nintedanib and miR-29b co-loaded lipoplexes in idiopathic pulmonary fibrosis: formulation, characterization, and in vitro evaluation;Drug Development and Industrial Pharmacy;2024-07-02

2. Application of PBPK Modeling in Formulation Development;Exploring Computational Pharmaceutics ‐ AI and Modeling in Pharma 4.0;2024-06-21

3. Ultrahigh yields of giant vesicles obtained through mesophase evolution and breakup;2024-06-04

4. Remotely controlled drug release in deep brain regions of non-human primates;Journal of Controlled Release;2024-05

5. Dispersion and Phase Exchange Process of Chemically Reactive Solute Through Circular Tube;Journal of Applied Fluid Mechanics;2024-04-01